JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB144573

Banoxantrone dihydrochloride (AQ4N), Topoisomerase II inhibitor

Be the first to review this product! Submit a review

|

(1 Publication)

MW 517.4 Da, Purity >97%. Bioreductive AQ4 precursor. Topoisomerase II inhibitor. Converts under hypoxia to DNA-affinic mitoxantrone (ab141041) structural analog. Induces DNA intercalation. Shows antitumor effects in vivo. .
1 Images
Chemical Structure - Banoxantrone dihydrochloride (AQ4N), Topoisomerase II inhibitor (AB144573)
  • Chemical Structure

Lab

Chemical Structure - Banoxantrone dihydrochloride (AQ4N), Topoisomerase II inhibitor (AB144573)

2D chemical structure image of ab144573, Banoxantrone dihydrochloride (AQ4N), Topoisomerase II inhibitor

Key facts

CAS number

252979-56-9

Purity

>97%

Form

Solid

form

Molecular weight

517.4 Da

Molecular formula

C<sub>2</sub><sub>2</sub>H<sub>3</sub><sub>0</sub>Cl<sub>2</sub>N<sub>4</sub>O<sub>6</sub>

PubChem

72941779

Nature

Synthetic

Solubility

Soluble in water to 25 mM

Biochemical name

Banoxantrone dihydrochloride

Biological description

Bioreductive AQ4 precursor. Topoisomerase II inhibitor. Converts under hypoxia to DNA-affinic mitoxantrone (ab141041) structural analog. Induces DNA intercalation. Shows antitumor effects in vivo.

Canonical smiles

C[N+](C)(CCNC1=C2C(=C(C=C1)NCC[N+](C)(C)[O-])C(=O)C3=C(C=CC(=C3C2=O)O)O)[O-].Cl.Cl

InChi

InChI=1S/C22H28N4O6.2ClH/c1-25(2,31)11-9-23-13-5-6-14(24-10-12-26(3,4)32)18-17(13)21(29)19-15(27)7-8-16(28)20(19)22(18)30;;/h5-8,23-24,27-28H,9-12H2,1-4H3;2*1H

InChiKey

SBWCPHUXRZRTDP-UHFFFAOYSA-N

IUPAC Name

2-[[4-[2-[dimethyl(oxido)azaniumyl]ethylamino]-5,8-dihydroxy-9,10-dioxoanthracen-1-yl]amino]-N,N-dimethylethanamine oxide;dihydrochloride

Properties and storage information

Shipped at conditions
Ambient - Can Ship with Ice
Appropriate short-term storage conditions
-20°C
Appropriate long-term storage conditions
-20°C
Storage information
It is important to note that this product is reported to be light sensitive|Store in the dark|Store under desiccating conditions

Product protocols

Publications (1)

Recent publications for all applications. Explore the full list and refine your search

Biomaterials 162:123-131 PubMed29438880

2018

Glucose & oxygen exhausting liposomes for combined cancer starvation and hypoxia-activated therapy.

Applications

Unspecified application

Species

Unspecified reactive species

Rui Zhang,Liangzhu Feng,Ziliang Dong,Li Wang,Chao Liang,Jiawen Chen,Qingxi Ma,Rui Zhang,Qian Chen,Yucai Wang,Zhuang Liu
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com